Nutritional assessment in cirrhotic patients with hepatic encephalopathy

World Journal of Hepatology

Volumn 7, Issue 30, 2015, Pages 2940-2954

  Romeiro, Fernando Gomes ^a   Augusti, Laís ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Anthropometry; Dual energy X ray absorptiometry; Electric impedance; Hepatic encephalopathy; Liver cirrhosis; Malnutrition; Muscle strength; Nutrition assessment

Indexed keywords

EID: 84952815217     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v7.i30.2940     Document Type: Article

References (114)

1. Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, Wong P. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 2014; 60: 715-735 [PMID: 25042402 DOI: 10.1002/hep.27210]
2. Poordad FF. Review article: the burden of hepatic encephalopathy. Aliment Pharmacol Ther 2007; 25: Suppl 1: 3-9 [PMID: 17295846 DOI: 10.1111/j.1746-6342.2006.03215.x]
3. Bass NM. Review article: the current pharmacological therapies for hepatic encephalopathy. Aliment Pharmacol Ther 2007; 25 Suppl 1: 23-31 [PMID: 17295849]
4. Ortiz M, Jacas C, Córdoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 2005; 42 Suppl: S45-S53 [PMID: 15777572 DOI: 10.1016/j.jhep.2004.11.028]
5. Moriwaki H, Shiraki M, Iwasa J, Terakura Y. Hepatic encephalopathy as a complication of liver cirrhosis: an Asian perspective. J Gastroenterol Hepatol 2010; 25: 858-863 [PMID: 20546438 DOI: 10.1111/j.1440-1746.2010.06242.x]
6. Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, Rodés J. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999; 30: 890-895 [PMID: 10365817 DOI: 10.1016/S0168-8278(99)80144-5]
7. Stewart CA, Malinchoc M, Kim WR, Kamath PS. Hepatic encephalopathy as a predictor of survival in patients with endstage liver disease. Liver Transpl 2007; 13: 1366-1371 [PMID: 17520742 DOI: 10.1002/lt.21129]
8. Jepsen P, Ott P, Andersen PK, Sørensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology 2010; 51: 1675-1682 [PMID: 20186844 DOI: 10.1002/hep.23500]
9. Montagnese S, De Rui M, Schiff S, Ceranto E, Valenti P, Angeli P, Cillo U, Zanus G, Gatta A, Amodio P, Merkel C. Prognostic benefit of the addition of a quantitative index of hepatic encephalopathy to the MELD score: the MELD-EEG. Liver Int 2015; 35: 58-64 [PMID: 24517387 DOI: 10.1111/liv.12490]
10. Yun BC, Kim WR. Hyponatremia in hepatic encephalopathy: an accomplice or innocent bystander? Am J Gastroenterol 2009; 104: 1390-1391 [PMID: 19455127 DOI: 10.1038/ajg.2009.287]
11. Alberino F, Gatta A, Amodio P, Merkel C, Di Pascoli L, Boffo G, Caregaro L. Nutrition and survival in patients with liver cirrhosis. Nutrition 2001; 17: 445-450 [PMID: 11399401 DOI: 10.1016/ S0899-9007(01)00521-4]
12. Fialla AD, Israelsen M, Hamberg O, Krag A, Gluud LL. Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta-analysis. Liver Int 2015; 35: 2072-2078 [PMID: 25645300 DOI: 10.1111/liv.12798]
13. Ney M, Abraldes JG, Ma M, Belland D, Harvey A, Robbins S, Den Heyer V, Tandon P. Insufficient Protein Intake Is Associated With Increased Mortality in 630 Patients With Cirrhosis Awaiting Liver Transplantation. Nutr Clin Pract 2015; 30: 530-536 [PMID: 25667232 DOI: 10.1177/0884533614567716]
14. Ruiz-Margáin A, Macías-Rodríguez RU, Duarte-Rojo A, Ríos-Torres SL, Espinosa-Cuevas Á, Torre A. Malnutrition assessed through phase angle and its relation to prognosis in patients with compensated liver cirrhosis: a prospective cohort study. Dig Liver Dis 2015; 47: 309-314 [PMID: 25618555 DOI: 10.1016/j. dld.2014.12.015]
15. Waghray A, Waghray N, Kanna S, Mullen K. Optimal treatment of hepatic encephalopathy. Minerva Gastroenterol Dietol 2014; 60: 55-70 [PMID: 24632768]
16. Walker V. Ammonia metabolism and hyperammonemic disorders. Adv Clin Chem 2014; 67: 73-150 [PMID: 25735860 DOI: 10.1016/ bs.acc.2014.09.002]
17. Romero-Gómez M, Montagnese S, Jalan R. Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. J Hepatol 2015; 62: 437-447 [PMID: 25218789 DOI: 10.1016/j.jhep.2014.09.005]
18. Al Sibae MR, McGuire BM. Current trends in the treatment of hepatic encephalopathy. Ther Clin Risk Manag 2009; 5: 617-626 [PMID: 19707277 DOI: 10.2147/TCRM.S4443]
19. Wilkinson DJ, Smeeton NJ, Watt PW. Ammonia metabolism, the brain and fatigue; revisiting the link. Prog Neurobiol 2010; 91: 200-219 [PMID: 20138956 DOI: 10.1016/j.pneurobio.2010.01.012]
20. Cooper AJ. The role of glutamine synthetase and glutamate dehydrogenase in cerebral ammonia homeostasis. Neurochem Res 2012; 37: 2439-2455 [PMID: 22618691 DOI: 10.1007/s11064-012-0803-4]
21. Prakash R, Mullen KD. Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol 2010; 7: 515-525 [PMID: 20703237 DOI: 10.1038/nrgastro.2010.116]
22. Wunsch E, Koziarska D, Milkiewicz M, Naprawa G, Nowacki P, Hartleb M, Milkiewicz P. In patients with liver cirrhosis, proinflammatory interleukins correlate with health-related quality of life irrespective of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol 2013; 25: 1402-1407 [PMID: 24025977 DOI: 10.1097/MEG.0b013e328365a447]
23. Romeiro FG, da Silva Yamashiro F, Américo MF, Corá LA, Silva GF, Miranda JR, Caramori CA. Erythromycin versus neomycin in the treatment of hepatic encephalopathy in cirrhosis: a randomized double-blind study. BMC Gastroenterol 2013; 13: 13 [PMID:23324408 DOI: 10.1186/1471-230X-13-13]
24. Alempijevic T, Štulic M, Popovic D, Culafic D, Dragasevic S, Milosavljevic T. The role of fecal calprotectin in assessment of hepatic encephalopathy in patients with liver cirrhosis. Acta Gastroenterol Belg 2014; 77: 302-305 [PMID: 25509200]
25. Bajaj JS, Betrapally NS, Hylemon PB, Heuman DM, Daita K, White MB, Unser A, Thacker LR, Sanyal AJ, Kang DJ, Sikaroodi M, Gillevet PM. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy. Hepatology 2015; 62: 1260-1271 [PMID: 25820757 DOI: 10.1002/hep.27819]
26. Nolan JP. The role of intestinal endotoxin in liver injury: a long and evolving history. Hepatology 2010; 52: 1829-1835 [PMID: 20890945 DOI: 10.1002/hep.23917]
27. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004; 39: 1441-1449 [PMID: 15122774 DOI: 10.1002/hep.20194]
28. Gupta A, Dhiman RK, Kumari S, Rana S, Agarwal R, Duseja A, Chawla Y. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J Hepatol 2010; 53: 849-855 [PMID: 20675008 DOI: 10.1016/j.jhep.2010.05.017]
29. John S, Thuluvath PJ. Hyponatremia in cirrhosis: pathophysiology and management. World J Gastroenterol 2015; 21: 3197-3205 [PMID: 25805925 DOI: 10.3748/wjg.v21.i11.3197]
30. Abu Hossain S, Chaudhry FA, Zahedi K, Siddiqui F, Amlal H. Cellular and molecular basis of increased ammoniagenesis in potassium deprivation. Am J Physiol Renal Physiol 2011; 301: F969-F978 [PMID: 21795646 DOI: 10.1152/ajprenal.00010.2011]
31. Yang SS, Lai YC, Chiang TR, Chen DF, Chen DS. Role of zinc in subclinical hepatic encephalopathy: comparison with somatosensory-evoked potentials. J Gastroenterol Hepatol 2004; 19: 375-379 [PMID: 15012773 DOI: 10.1111/j.1440-1746.2003.03281.x]
32. Amodio P, Bemeur C, Butterworth R, Cordoba J, Kato A, Montagnese S, Uribe M, Vilstrup H, Morgan MY. The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Hepatology 2013; 58: 325-336 [PMID: 23471642 DOI: 10.1002/hep.26370]
33. Romeiro FG, Américo MF, Yamashiro FS, Caramori CA, Schelp AO, Santos AC, Silva GF. Acquired hepatocerebral degeneration and hepatic encephalopathy: correlations and variety of clinical presentations in overt and subclinical liver disease. Arq Neuropsiquiatr 2011; 69: 496-501 [PMID: 21755129 DOI: 10.1590/S0004-282X2011000400017]
34. Maffeo E, Montuschi A, Stura G, Giordana MT. Chronic acquired hepatocerebral degeneration, pallidal T1 MRI hyperintensity and manganese in a series of cirrhotic patients. Neurol Sci 2014; 35: 523-530 [PMID: 23712371 DOI: 10.1007/s10072-013-1458-x]
35. Gluud LL, Dam G, Les I, Córdoba J, Marchesini G, Borre M, Aagaard NK, Vilstrup H. Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev 2015; 2: CD001939 [PMID: 25715177 DOI: 10.1002/14651858.CD001939.pub2]
36. Zhu GQ, Shi KQ, Huang S, Wang LR, Lin YQ, Huang GQ, Chen YP, Braddock M, Zheng MH. Systematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy. Aliment Pharmacol Ther 2015; 41: 624-635 [PMID: 25684317 DOI: 10.1111/apt.13122]
37. Kalaitzakis E, Olsson R, Henfridsson P, Hugosson I, Bengtsson M, Jalan R, Björnsson E. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis. Liver Int 2007; 27: 1194-1201 [PMID: 17919230 DOI: 10.1111/ j.1478-3231.2007.01562.x]
38. Huisman EJ, Trip EJ, Siersema PD, van Hoek B, van Erpecum KJ. Protein energy malnutrition predicts complications in liver cirrhosis. Eur J Gastroenterol Hepatol 2011; 23: 982-989 [PMID: 21971339 DOI: 10.1097/MEG.0b013e32834aa4bb]
39. Merli M, Giusto M, Lucidi C, Giannelli V, Pentassuglio I, Di Gregorio V, Lattanzi B, Riggio O. Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study. Metab Brain Dis 2013; 28: 281-284 [PMID: 23224378 DOI: 10.1007/s11011-012-9365-z]
40. Periyalwar P, Dasarathy S. Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses. Clin Liver Dis 2012; 16: 95-131 [PMID: 22321468 DOI: 10.1016/j.cld.2011.12.009]
41. Berzigotti A, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Morillas R, Escorsell A, Garcia-Pagan JC, Patch D, Matloff DS, Groszmann RJ. Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology 2011; 54: 555-561 [PMID: 21567436 DOI: 10.1002/hep.24418]
42. Everhart JE, Lok AS, Kim HY, Morgan TR, Lindsay KL, Chung RT, Bonkovsky HL, Ghany MG; HALT-C Trial Group. Weightrelated effects on disease progression in the hepatitis C antiviral longterm treatment against cirrhosis trial. Gastroenterology 2009; 137: 549-557 [PMID: 19445938 DOI: 10.1053/j. gastro.2009.05.007]
43. Jeejeebhoy KN. Malnutrition, fatigue, frailty, vulnerability, sarcopenia and cachexia: overlap of clinical features. Curr Opin Clin Nutr Metab Care 2012; 15: 213-219 [PMID: 22450775 DOI: 10.1097/MCO.0b013e328352694f]
44. Prado CM, Wells JC, Smith SR, Stephan BC, Siervo M. Sarcopenic obesity: A Critical appraisal of the current evidence. Clin Nutr 2012; 31: 583-601 [PMID: 22809635 DOI: 10.1016/j.clnu.2012.06.010]
45. Dupont B, Dao T, Joubert C, Dupont-Lucas C, Gloro R, Nguyen-Khac E, Beaujard E, Mathurin P, Vastel E, Musikas M, Ollivier I, Piquet MA. Randomised clinical trial: enteral nutrition does not improve the long-term outcome of alcoholic cirrhotic patients with jaundice. Aliment Pharmacol Ther 2012; 35: 1166-1174 [PMID: 22452620 DOI: 10.1111/j.1365-2036.2012.05075.x]
46. Campillo B, Richardet JP, Scherman E, Bories PN. Evaluation of nutritional practice in hospitalized cirrhotic patients: results of a prospective study. Nutrition 2003; 19: 515-521 [PMID: 12781851 DOI: 10.1016/S0899-9007(02)01071-7]
47. Roongpisuthipong C, Sobhonslidsuk A, Nantiruj K, Songchitsomboon S. Nutritional assessment in various stages of liver cirrhosis. Nutrition 2001; 17: 761-765 [PMID: 11527674 DOI: 10.1016/S0899-9007(01)00626-8]
48. Carvalho L, Parise ER. Evaluation of nutritional status of nonhospitalized patients with liver cirrhosis. Arq Gastroenterol 2006; 43: 269-274 [PMID: 17406753 DOI: 10.1590/S0004-28032006000400005]
49. Plauth M, Cabré E, Riggio O, Assis-Camilo M, Pirlich M, Kondrup J, Ferenci P, Holm E, Vom Dahl S, Müller MJ, Nolte W. ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr 2006; 25: 285-294 [PMID: 16707194 DOI: 10.1016/j.clnu.2006.01.018]
50. Cheung K, Lee SS, Raman M. Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies. Clin Gastroenterol Hepatol 2012; 10: 117-125 [PMID: 21893127 DOI: 10.1016/j.cgh.2011.08.016]
51. Moctezuma-Velázquez C, García-Juárez I, Soto-Solís R, Hernández-Cortés J, Torre A. Nutritional assessment and treatment of patients with liver cirrhosis. Nutrition 2013; 29: 1279-1285 [PMID: 23867207 DOI: 10.1016/j.nut.2013.03.017]
52. McCullough AJ, Mullen KD, Kalhan SC. Measurements of total body and extracellular water in cirrhotic patients with and without ascites. Hepatology 1991; 14: 1102-1111 [PMID: 1959861 DOI: 10.1002/hep.1840140626]
53. Oldroyd B, Bramley PN, Stewart SP, Simpson M, Truscott JG, Losowsky MS, Smith MA. A four-compartment model to determine body composition in liver cirrhosis. Basic Life Sci 1993; 60: 221-224 [PMID: 8110115 DOI: 10.1007/978-1-4899-1268-8_5 1]
54. Madden AM, Morgan MY. The potential role of dual-energy X-ray absorptiometry in the assessment of body composition in cirrhotic patients. Nutrition 1997; 13: 40-45 [PMID: 9058447 DOI: 10.1016/S0899-9007(97)90877-7]
55. Chadalavada R, Sappati Biyyani RS, Maxwell J, Mullen K. Nutrition in hepatic encephalopathy. Nutr Clin Pract 2010; 25: 257-264 [PMID: 20581319 DOI: 10.1177/0884533610368712]
56. Morgan MY, Madden AM, Jennings G, Elia M, Fuller NJ. Twocomponent models are of limited value for the assessment of body composition in patients with cirrhosis. Am J Clin Nutr 2006; 84: 1151-1162 [PMID: 17093169]
57. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, Jeejeebhoy KN. What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 1987; 11: 8-13 [PMID: 3820522 DOI: 10.1177/014860718701100 108]
58. Matos C, Porayko MK, Francisco-Ziller N, DiCecco S. Nutrition and chronic liver disease. J Clin Gastroenterol 2002; 35: 391-397 [PMID: 12394227 DOI: 10.1097/00004836-200211000-00007]
59. Campillo B, Richardet JP, Bories PN. Validation of body mass index for the diagnosis of malnutrition in patients with liver cirrhosis. Gastroenterol Clin Biol 2006; 30: 1137-1143 [PMID: 17075467]
60. Fiore P, Merli M, Andreoli A, De Lorenzo A, Masini A, Ciuffa L, Valeriano V, Balotta MT, Riggio O. A comparison of skinfold anthropometry and dual-energy X-ray absorptiometry for the evaluation of body fat in cirrhotic patients. Clin Nutr 1999; 18: 349-351 [PMID: 10634919 DOI: 10.1016/S0261-5614(99)80014-4]
61. Guex E, Cheseaux M, Bertrand PC, Piquet MA, Bouvry S, Pilon N, Halkic N, Pascual M, Roulet M. [Prevalence of undernutrition in 143 patients before liver transplantation The Lausanne experience between 1997 and 2005]. Rev Med Suisse 2008; 4: 927-930 [PMID: 18578434]
62. Harrison J, McKiernan J, Neuberger JM. A prospective study on the effect of recipient nutritional status on outcome in liver transplantation. Transpl Int 1997; 10: 369-374 [PMID: 9287402 DOI: 10.1111/j.1432-2277.1997.tb00931.x]
63. Morgan MY, Madden AM, Soulsby CT, Morris RW. Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis. Hepatology 2006; 44: 823-835 [PMID: 17006918 DOI: 10.1002/hep.21358]
64. Bémeur C, Desjardins P, Butterworth RF. Role of nutrition in the management of hepatic encephalopathy in end-stage liver failure. J Nutr Metab 2010; 2010: 489823 [PMID: 21234351 DOI: 10.1155/2010/489823]
65. Lameu EB, Gerude MF, Campos AC, Luiz RR. The thickness of the adductor pollicis muscle reflects the muscle compartment and may be used as a new anthropometric parameter for nutritional assessment. Curr Opin Clin Nutr Metab Care 2004; 7: 293-301 [PMID: 15075921 DOI: 10.1097/00075197-200405000-00009]
66. de Oliveira CM, Kubrusly M, Mota RS, Choukroun G, Neto JB, da Silva CA. Adductor pollicis muscle thickness: a promising anthropometric parameter for patients with chronic renal failure. J Ren Nutr 2012; 22: 307-316 [PMID: 22056150 DOI: 10.1053/ j.jrn.2011.07.006]
67. Bering T, Maurício SF, Silva JB, Correia MI. Nutritional and metabolic status of breast cancer women. Nutr Hosp 2015; 31: 751-758 [PMID: 25617559 DOI: 10.3305/nh.2015.31.2.8056]
68. Gonzalez MC, Pureza Duarte RR, Orlandi SP, Bielemann RM, Barbosa-Silva TG. Adductor pollicis muscle: A study about its use as a nutritional parameter in surgical patients. Clin Nutr 2015; 34: 1025-1029 [PMID: 25467064 DOI: 10.1016/j.clnu.2014.11.006]
69. Thomas BJ, Cornish BH, Ward LC. Bioelectrical impedance analysis for measurement of body fluid volumes: a review. J Clin Eng 1992; 17: 505-510 [PMID: 10124463 DOI: 10.1097/00004669-199211000-00016]
70. Pirlich M, Schütz T, Spachos T, Ertl S, Weiss ML, Lochs H, Plauth M. Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology 2000; 32: 1208-1215 [PMID: 11093726 DOI: 10.1053/jhep.2000.20524]
71. Cabré E, Gassull MA. Nutritional aspects of liver disease and transplantation. Curr Opin Clin Nutr Metab Care 2001; 4: 581-589 [PMID: 11706297 DOI: 10.1097/00075197-200111000-00020]
72. Selberg O, Selberg D. Norms and correlates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis. Eur J Appl Physiol 2002; 86: 509-516 [PMID: 11944099 DOI: 10.1007/s00421-001-0570-4]
73. Norman K, Kirchner H, Lochs H, Pirlich M. Malnutrition affects quality of life in gastroenterology patients. World J Gastroenterol 2006; 12: 3380-3385 [PMID: 16733855 DOI: 10.3748/wjg.v12.i21.3385]
74. Fernandes SA, Bassani L, Nunes FF, Aydos ME, Alves AV, Marroni CA. Nutritional assessment in patients with cirrhosis. Arq Gastroenterol 2012; 49: 19-27 [PMID: 22481682 DOI: 10.1590/S0004-28032012000100005]
75. Peres WA, Lento DF, Baluz K, Ramalho A. Phase angle as a nutritional evaluation tool in all stages of chronic liver disease. Nutr Hosp 2012; 27: 2072-2078 [PMID: 23588459 DOI: 10.3305/ nh.2012.27.6.6015]
76. Kalafateli M, Triantos C, Tsochatzis E, Michalaki M, Koutroumpakis E, Thomopoulos K, Kyriazopoulou V, Jelastopulu E, Burroughs A, Lambropoulou-Karatza C, Nikolopoulou V. Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosis. World J Gastroenterol 2015; 21: 3020-3029 [PMID: 25780301 DOI: 10.3748/wjg.v21.i10.3020]
77. Liboredo JC, Vilela EG, Ferrari Mde L, Lima AS, Correia MI. Nutrition status and intestinal permeability in patients eligible for liver transplantation. JPEN J Parenter Enteral Nutr 2015; 39: 163-170 [PMID: 24255087 DOI: 10.1177/0148607113513465]
78. Selberg O, Böttcher J, Tusch G, Pichlmayr R, Henkel E, Müller MJ. Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 1997; 25: 652-657 [PMID: 9049214 DOI: 10.1002/hep.510250327]
79. Figueiredo FA, Dickson ER, Pasha TM, Porayko MK, Therneau TM, Malinchoc M, DiCecco SR, Francisco-Ziller NM, Kasparova P, Charlton MR. Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease. Liver Transpl 2000; 6: 575-581 [PMID: 10980056 DOI: 10.1053/jlts.2000.9736]
80. Müller MJ, Lautz HU, Plogmann B, Bürger M, Körber J, Schmidt FW. Energy expenditure and substrate oxidation in pients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 1992; 15: 782-794 [PMID: 1568718 DOI: 10.1002/ hep.1840150507]
81. Madden AM, Morgan MY. A comparison of skinfold anthropometry and bioelectrical impedance analysis for measuring percentage body fat in patients with cirrhosis. J Hepatol 1994; 21: 878-883 [PMID: 7890906 DOI: 10.1016/S0168-8278(94)80253-X]
82. Wu TJ, Huang JJ, Lin CY. Effects of fluid retention on the measurement of body composition using bioelectric impedance. J Formos Med Assoc 1994; 93: 939-943 [PMID: 7633198]
83. Panella C, Guglielmi FW, Mastronuzzi T, Francavilla A. Wholebody and segmental bioelectrical parameters in chronic liver disease: effect of gender and disease stages. Hepatology 1995; 21: 352-358 [PMID: 7843705 DOI: 10.1002/hep.1840210214]
84. Lehnert ME, Clarke DD, Gibbons JG, Ward LC, Golding SM, Shepherd RW, Cornish BH, Crawford DH. Estimation of body water compartments in cirrhosis by multiple-frequency bioelectrical-impedance analysis. Nutrition 2001; 17: 31-34 [PMID: 11165885 DOI: 10.1016/S0899-9007(00)00473-1]
85. Guglielmi FW, Contento F, Laddaga L, Panella C, Francavilla A. Bioelectric impedance analysis: experience with male patients with cirrhosis. Hepatology 1991; 13: 892-895 [PMID: 2029993 DOI: 10.1002/hep.1840130515]
86. Zillikens MC, van den Berg JW, Wilson JH, Swart GR. Wholebody and segmental bioelectrical-impedance analysis in patients with cirrhosis of the liver: changes after treatment of ascites. Am J Clin Nutr 1992; 55: 621-625 [PMID: 1550033]
87. Sörös P, Böttcher J, Weissenborn K, Selberg O, Müller MJ. Malnutrition and hypermetabolism are not risk factors for the presence of hepatic encephalopathy: a cross-sectional study. J Gastroenterol Hepatol 2008; 23: 606-610 [PMID: 18005013 DOI: 10.1111/j.1440-1746.2007.05222.x]
88. Böhm D, Odaischi M, Beyerlein C, Overbeck W. Total body water: changes during dialysis estimated by bioimpedance analysis. Infusionstherapie 1990; 17 Suppl 3: 75-78 [PMID: 2401575]
89. Kurtin PS, Shapiro AC, Tomita H, Raizman D. Volume status and body composition of chronic dialysis patients: utility of bioelectric impedance plethysmography. Am J Nephrol 1990; 10: 363-367 [PMID: 2080787 DOI: 10.1159/000168151]
90. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310 [PMID: 2868172 DOI: 10.1016/S0140- 6736(86)90837 -8]
91. Montano-Loza AJ. Clinical relevance of sarcopenia in patients with cirrhosis. World J Gastroenterol. 2014; 20: 8061-8071 [PMID: 25009378 DOI: 10.3748/wjg.v20.i25.8061]
92. Zillikens MC, van den Berg JW, Wilson JH, Rietveld T, Swart GR. The validity of bioelectrical impedance analysis in estimating total body water in patients with cirrhosis. J Hepatol. 1992; 16: 59-65 [PMID: 1484169 DOI: 10.1016/S0168-8278(05)80095-9]
93. Malaguarnera M, Vacante M, Giordano M, Pennisi G, Bella R, Rampello L, Malaguarnera M, Li Volti G, Galvano F. Oral acetyl-Lcarnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Am J Clin Nutr. 2011; 93: 799-808 [PMID: 21310833 DOI: 10.3945/ ajcn.110.007393]
94. Banister EW, Cameron BJ. Exercise-induced hyperammonemia: peripheral and central effects. Int J Sports Med. 1990; 11 Suppl 2: S129-S142 [PMID: 2193891 DOI: 10.1055/s-2007-1024864]
95. Hayashi F, Matsumoto Y, Momoki C, Yuikawa M, Okada G, Hamakawa E, Kawamura E, Hagihara A, Toyama M, Fujii H, Kobayashi S, Iwai S, Morikawa H, Enomoto M, Tamori A, Kawada N, Habu D. Physical inactivity and insufficient dietary intake are associated with the frequency of sarcopenia in patients with compensated viral liver cirrhosis. Hepatol Res. 2013; 43: 1264-1275 [PMID: 23489325 DOI: 10.1111/hepr.12085]
96. Alvares-da-Silva MR, Reverbel da Silveira T. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition. 2005; 21: 113-117 [PMID: 15723736 DOI: 10.1016/j.nut.2004.02.002]
97. Peng S, Plank LD, McCall JL, Gillanders LK, McIlroy K, Gane EJ. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study. Am J Clin Nutr. 2007; 85: 1257-1266 [PMID: 17490961]
98. Kohrt WM. Body composition by DXA: tried and true? Med Sci Sports Exerc 1995; 27: 1349-1353 [PMID: 8531604]
99. Kim J, Wang Z, Heymsfield SB, Baumgartner RN, Gallagher D. Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method. Am J Clin Nutr 2002; 76: 378-383 [PMID: 12145010]
100. Bosy-Westphal A, Müller MJ. Identification of skeletal muscle mass depletion across age and BMI groups in health and disease-- there is need for a unified definition. Int J Obes (Lond). 2015; 39: 379-386 [PMID: 25174451 DOI: 10.1038/ijo.2014.161]
101. Riggio O, Andreoli A, Diana F, Fiore P, Meddi P, Lionetti R, Montagnese F, Merli M, Capocaccia L, De Lorenzo A. Whole body and regional body composition analysis by dual-energy X-ray absorptiometry in cirrhotic patients. Eur J Clin Nutr. 1997; 51: 810-814 [PMID: 9426355]
102. Bramley P, Oldroyd B, Stewart S, Simpson M, Truscott J, Losowsky M, Smith M. Body composition analysis in liver cirrhosis. The measurement of body fat by dual energy X-ray absorptiometry in comparison to skinfold anthropometry, bioelectrical impedance and total body potassium. Basic Life Sci. 1993; 60: 211-214 [PMID: 8110112 DOI: 10.1007/978-1-4899-1268-8_48]
103. Kalaitzakis E, Josefsson A, Castedal M, Henfridsson P, Bengtsson M, Andersson B, Björnsson E. Hepatic encephalopathy is related to anemia and fat-free mass depletion in liver transplant candidates with cirrhosis. Scand J Gastroenterol. 2013; 48: 577-584 [PMID: 23452072 DOI: 10.3109/00365521.2013.777468]
104. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998; 147: 755-763 [PMID: 9554417 DOI: 10.1093/oxfordjournals. aje.a009520]
105. Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci. 2000; 904: 437-448 [PMID: 10865787 DOI: 10.1111/ j.1749-6632.2000.tb06498.x]
106. Giusto M, Lattanzi B, Albanese C, Galtieri A, Farcomeni A, Giannelli V, Lucidi C, Di Martino M, Catalano C, Merli M. Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry. Eur J Gastroenterol Hepatol. 2015; 27: 328-334 [PMID: 25569567 DOI: 10.1097/ MEG.0000000000000274]
107. Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, Sawyer MB. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012; 10: 166-173, 173.e1 [PMID: 21893129 DOI: 10.1016/j. cgh.2011.08.028]
108. Durand F, Buyse S, Francoz C, Laouénan C, Bruno O, Belghiti J, Moreau R, Vilgrain V, Valla D. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. J Hepatol. 2014; 60: 1151-1157 [PMID: 24607622 DOI: 10.1016/ j.jhep.2014.02.026]
109. Hanai T, Shiraki M, Nishimura K, Ohnishi S, Imai K, Suetsugu A, Takai K, Shimizu M, Moriwaki H. Sarcopenia impairs prognosis of patients with liver cirrhosis. Nutrition. 2015; 31: 193-199 [PMID: 25441595 DOI: 10.1016/j.nut.2014.07.005]
110. Montano-Loza AJ, Meza-Junco J, Prado CMM, Tandon P, Bain VG, Ma M, Beaumont C, Esfandiari N, Sawyer MB, Baracos VE. New cutoff values for sarcopenia for predicting 6-months mortality in cirrhotic patients. J Hepatol. 2013; 58: S95 [DOI: 10.1016/ S0168-8278(13)60223-8]
111. Strauss BJ, Gibson PR, Stroud DB, Borovnicar DJ, Xiong DW, Keogh J. Total body dual X-ray absorptiometry is a good measure of both fat mass and fat-free mass in liver cirrhosis compared to gold-standard techniques. Melbourne Liver Group. Ann N Y Acad Sci. 2000; 904: 55-62 [PMID: 10865710 DOI: 10.1111/ j.1749-6632.2000.tb06421.x]
112. Figueiredo FA, Perez RM, Freitas MM, Kondo M. Comparison of three methods of nutritional assessment in liver cirrhosis: subjective global assessment, traditional nutritional parameters, and body composition analysis. J Gastroenterol. 2006; 41: 476-482 [PMID: 16799890 DOI: 10.1007/s00535-006-1794-1]
113. Plauth M, Merli M, Kondrup J, Weimann A, Ferenci P, Müller MJ. ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr. 1997; 16: 43-55 [PMID: 16844569 DOI: 10.1016/ S0261-5614(97)80022-2]
114. Francoz C, Prié D, Abdelrazek W, Moreau R, Mandot A, Belghiti J, Valla D, Durand F. Inaccuracies of creatinine and creatininebased equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score. Liver Transpl. 2010; 16: 1169-1177 [PMID: 20879015 DOI: 10.1002/lt.22128]